Currently out of the existing stock ratings of Sidharth Sahoo, 3 are a HOLD (33.33%), 6 are a BUY (66.67%).

Sidharth Sahoo

Work Performance Price Targets & Ratings Chart

Analyst Sidharth Sahoo, currently employed at HSBC, carries an average stock price target met ratio of 25% that have a potential upside of 6.93% achieved within 45 days.

Sidharth Sahoo’s has documented 22 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on RGEN, Repligen at 03-Jun-2026.

Wall Street Analyst Sidharth Sahoo

Analyst best performing recommendations are on UNH (UNITEDHEALTH GROUP).
The best stock recommendation documented was for UNH (UNITEDHEALTH GROUP) at 6/5/2024. The price target of $580 was fulfilled within 91 days with a profit of $98.38 (20.43%) receiving and performance score of 2.24.

Average potential price target upside

TMO Thermo Fisher Scientific RGEN Repligen ALGN Align Technology UNH UnitedHealth Group

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 03-Jun-2026

$540

$26.97 (5.26%)

$670

1 months 5 days ago
(03-Jun-2026)

0/2 (0%)

$66.05 (13.94%)

Hold Since 15-May-2026

$490

$-23.03 (-4.49%)

$561

1 months 23 days ago
(15-May-2026)

5/16 (31.25%)

$51.66 (11.79%)

120

Buy Since 03-Jun-2024

$615

$101.97 (19.88%)

$675

2 months ago
(08-May-2026)

3/8 (37.5%)

$150 (32.26%)

253

Buy Since 10-Jan-2014

$600

$86.97 (16.95%)

$700

2 months 14 days ago
(24-Apr-2026)

9/16 (56.25%)

$130.29 (27.74%)

172

Buy Since 26-Mar-2019

$639

$115.56 (22.08%)

$567

2 months 14 days ago
(24-Apr-2026)

22/29 (75.86%)

$169.29 (36.04%)

178

Show more analysts

Please expand the browser size to see the chart

Which stock is Sidharth Sahoo is most bullish on?

Potential upside of $16.56 has been obtained for TMO (THERMO FISHER SCIENTIFIC)

Which stock is Sidharth Sahoo is most reserved on?

Potential downside of $7.6 has been obtained for RGEN (REPLIGEN)

What Year was the first public recommendation made by Sidharth Sahoo?

On 2023

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?